Sfoglia per Titolo
Nissen fundoplication after failure of endoluminal fundoplication: short term results
2011-01-01 Fumagalli Romario, U.; Barbera, R.; Repici, A.; Porta, M.; Malesci, A.; Rosati, R.
Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely Vasovagal syncope
2014-01-01 Petix, N. R.; Del Rosso, A.; Furlan, R.; Guarnaccia, V.; Zipoli, A.
Nitric oxide synthase mediates PC12 differentiation induced by the surface topography of nanostructured TiO2
2013-01-01 Tamplenizza, M.; Lenardi, C.; Maffioli, E.; Nonnis, S.; Negri, A.; Forti, S.; Sogne, E.; De Astis, S.; Matteoli, M.; Schulte, C.; Milani, P.; Tedeschi, G.
Nitrosamines and Heme Iron and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2012-01-01 Jakszyn, Pg; Allen, Ne; Lujan-Barroso, L; Gonzalez, Ca; Key, Tj; Fonseca-Nunes, A; Tjonneland, A; Fons-Johnsen, N; Overvad, K; Teucher, B; Li, Kr; Boeing, H; Trichopoulou, A; Oikonomou, E; Sarantopoulou, M; Saieva, C; Krogh, V; Tumino, R; Ricceri, F; Bueno-de-Mesquita, Hb; Huerta, Jm; Ardanaz, E; Arguelles, Mv; Molina-Montes, E; Larranaga, N; Wirfalt, E; Wallstrom, P; Johansson, M; Stattin, P; Khaw, Kt; Jenab, M; Fedirko, V; Riboli, E
Nitrosoureas: molecular pharmacology/ translational research
2007-01-01 D'Incalci, Maurizio
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040
2019-01-01 Yau, T; Kang, Yk; Kim, Ty; El-Khoueiry, Ab; Santoro, A; Sangro, B; Melero, I; Kudo, M; Hou, Mm; Matilla, A; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, Bf; Acosta-Rivera, M; Neely, J; Shen, Y; Baccan, C; Dela Cruz, Cm; Hsu, C
Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study
2019-01-01 Zinzani, Pl; Santoro, A; Gritti, G; Brice, P; Barr, Pm; Kuruvilla, J; Cunningham, D; Kline, J; Johnson, Na; Mehta-Shah, Na; Manley, T; Francis, S; Sharma, M; Moskowitz, Aj
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
2023-01-01 Zinzani, Pier Luigi; Santoro, Armando; Gritti, Giuseppe; Brice, Pauline; Barr, Paul M; Kuruvilla, John; Cunningham, David; Kline, Justin; Johnson, Nathalie A; Mehta-Shah, Neha; Lisano, Julie M; Wen, Rachael; Akyol, Alev; Moskowitz, Alison J
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
2023-01-01 Santoro, Armando; Moskowitz, Alison J; Ferrari, Silvia; Carlo-Stella, Carmelo; Lisano, Julie M; Francis, Stephen; Wen, Rachael; Akyol, Alev; Savage, Kerry J
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicenter, multicohort, single-arm phase 2 trial
2016-01-01 Younes, A; Santoro, A; Shipp, M; Zinzani, P L; Timmerman, J M; Ansell, S; Armand, P; Fanale, M; Ratanatharathorn, V; Kuruvilla, J; Cohen, J B; Collins, G; Savage, K J; Trneny, M; Kato, K; Farsaci, B; Parker, S M; Rodig, S; Roemer, M G M; Ligon, A H
Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial
2018-01-01 Armand, P; Engert, A; Younes, A; Fanale, M; Santoro, A; Zinzani, P L; Timmerman, J M; Collins, G P; Ramchandren, R; Cohen, J B; De Boer, J P; Kuruvilla, J; Savage, K J; Trneny, M; Shipp, M A; Kato, K; Sumbul, A; Farsaci, B; Ansell, S M
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study
2023-01-01 Ansell, Stephen M; Bröckelmann, Paul J; von Keudell, Gottfried; Lee, Hun Ju; Santoro, Armando; Zinzani, Pier Luigi; Collins, Graham P; Cohen, Jonathon B; de Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trněný, Marek; Provencio, Mariano; Jaeger, Ulrich; Willenbacher, Wolfgang; Wen, Rachael; Akyol, Alev; Mikita-Geoffroy, Joanna; Shipp, Margaret A; Engert, Andreas Michael; Armand, Philippe
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience
2019-01-01 Rossi, S; Finocchiaro, G; Toschi, L; Santoro, A
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
2022-01-01 Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B; Sangro, Bruno; Eldawy, Tarek E; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M; Tschaika, Marina; Scheffold, Christian; Koopmans, Petra; Neely, Jaclyn; Piscaglia, Fabio
Nivolumab treatment beyond investigator-assessed progression: outcome in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 Checkmate 205 Study
2018-01-01 Cohen, J B; Engert, A; Ansell, S M; Younes, A; Trneny, M; Savage, K J; Ramchadren, R; Collins, G P; Fanale, M A; Armand, P; Zinzani, P L; De Boer, J P; Shipp, M A; Santoro, A; Timmerman, J M; Sacchi, M; Sy, O; Kuruvilla, J
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
2023-01-01 Portale, Federica; Di Mitri, Diletta
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
2018-01-01 Bottcher, Jp; Bonavita, E; Chakravarty, P; Blees, H; Cabeza-Cabrerizo, M; Sammicheli, S; Rogers, Nc; Sahai, E; Zelenay, S; Reis, e Sousa C
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions
2021-01-01 Cazzetta, Valentina; Bruni, Elena; Terzoli, Sara; Carenza, Claudia; Franzese, Sara; Piazza, Rocco; Marzano, Paolo; Donadon, Matteo; Torzilli, Guido; Cimino, Matteo; Simonelli, Matteo; Bello, Lorenzo; Villa, Anna; Tan, Likai; Ravens, Sarina; Prinz, Immo; Supino, Domenico; Colombo, Federico S; Lugli, Enrico; Marcenaro, Emanuela; Vivier, Eric; Della Bella, Silvia; Mikulak, Joanna; Mavilio, Domenico
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer
2019-01-01 Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico
No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study
2018-01-01 Levi-Setti, P; Cirillo, F; Smeraldi, A; Morenghi, E; Mulazzani, Geg; Albani, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Nissen fundoplication after failure of endoluminal fundoplication: short term results | 1-gen-2011 | Fumagalli Romario, U.; Barbera, R.; Repici, A.; Porta, M.; Malesci, A.; Rosati, R. | |
| Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely Vasovagal syncope | 1-gen-2014 | Petix, N. R.; Del Rosso, A.; Furlan, R.; Guarnaccia, V.; Zipoli, A. | |
| Nitric oxide synthase mediates PC12 differentiation induced by the surface topography of nanostructured TiO2 | 1-gen-2013 | Tamplenizza, M.; Lenardi, C.; Maffioli, E.; Nonnis, S.; Negri, A.; Forti, S.; Sogne, E.; De Astis, S.; Matteoli, M.; Schulte, C.; Milani, P.; Tedeschi, G. | |
| Nitrosamines and Heme Iron and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition | 1-gen-2012 | Jakszyn, Pg; Allen, Ne; Lujan-Barroso, L; Gonzalez, Ca; Key, Tj; Fonseca-Nunes, A; Tjonneland, A; Fons-Johnsen, N; Overvad, K; Teucher, B; Li, Kr; Boeing, H; Trichopoulou, A; Oikonomou, E; Sarantopoulou, M; Saieva, C; Krogh, V; Tumino, R; Ricceri, F; Bueno-de-Mesquita, Hb; Huerta, Jm; Ardanaz, E; Arguelles, Mv; Molina-Montes, E; Larranaga, N; Wirfalt, E; Wallstrom, P; Johansson, M; Stattin, P; Khaw, Kt; Jenab, M; Fedirko, V; Riboli, E | |
| Nitrosoureas: molecular pharmacology/ translational research | 1-gen-2007 | D'Incalci, Maurizio | |
| Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040 | 1-gen-2019 | Yau, T; Kang, Yk; Kim, Ty; El-Khoueiry, Ab; Santoro, A; Sangro, B; Melero, I; Kudo, M; Hou, Mm; Matilla, A; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, Bf; Acosta-Rivera, M; Neely, J; Shen, Y; Baccan, C; Dela Cruz, Cm; Hsu, C | |
| Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study | 1-gen-2019 | Zinzani, Pl; Santoro, A; Gritti, G; Brice, P; Barr, Pm; Kuruvilla, J; Cunningham, D; Kline, J; Johnson, Na; Mehta-Shah, Na; Manley, T; Francis, S; Sharma, M; Moskowitz, Aj | |
| Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up | 1-gen-2023 | Zinzani, Pier Luigi; Santoro, Armando; Gritti, Giuseppe; Brice, Pauline; Barr, Paul M; Kuruvilla, John; Cunningham, David; Kline, Justin; Johnson, Nathalie A; Mehta-Shah, Neha; Lisano, Julie M; Wen, Rachael; Akyol, Alev; Moskowitz, Alison J | |
| Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma | 1-gen-2023 | Santoro, Armando; Moskowitz, Alison J; Ferrari, Silvia; Carlo-Stella, Carmelo; Lisano, Julie M; Francis, Stephen; Wen, Rachael; Akyol, Alev; Savage, Kerry J | |
| Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicenter, multicohort, single-arm phase 2 trial | 1-gen-2016 | Younes, A; Santoro, A; Shipp, M; Zinzani, P L; Timmerman, J M; Ansell, S; Armand, P; Fanale, M; Ratanatharathorn, V; Kuruvilla, J; Cohen, J B; Collins, G; Savage, K J; Trneny, M; Kato, K; Farsaci, B; Parker, S M; Rodig, S; Roemer, M G M; Ligon, A H | |
| Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial | 1-gen-2018 | Armand, P; Engert, A; Younes, A; Fanale, M; Santoro, A; Zinzani, P L; Timmerman, J M; Collins, G P; Ramchandren, R; Cohen, J B; De Boer, J P; Kuruvilla, J; Savage, K J; Trneny, M; Shipp, M A; Kato, K; Sumbul, A; Farsaci, B; Ansell, S M | |
| Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study | 1-gen-2023 | Ansell, Stephen M; Bröckelmann, Paul J; von Keudell, Gottfried; Lee, Hun Ju; Santoro, Armando; Zinzani, Pier Luigi; Collins, Graham P; Cohen, Jonathon B; de Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trněný, Marek; Provencio, Mariano; Jaeger, Ulrich; Willenbacher, Wolfgang; Wen, Rachael; Akyol, Alev; Mikita-Geoffroy, Joanna; Shipp, Margaret A; Engert, Andreas Michael; Armand, Philippe | |
| Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience | 1-gen-2019 | Rossi, S; Finocchiaro, G; Toschi, L; Santoro, A | |
| Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial | 1-gen-2022 | Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B; Sangro, Bruno; Eldawy, Tarek E; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M; Tschaika, Marina; Scheffold, Christian; Koopmans, Petra; Neely, Jaclyn; Piscaglia, Fabio | |
| Nivolumab treatment beyond investigator-assessed progression: outcome in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 Checkmate 205 Study | 1-gen-2018 | Cohen, J B; Engert, A; Ansell, S M; Younes, A; Trneny, M; Savage, K J; Ramchadren, R; Collins, G P; Fanale, M A; Armand, P; Zinzani, P L; De Boer, J P; Shipp, M A; Santoro, A; Timmerman, J M; Sacchi, M; Sy, O; Kuruvilla, J | |
| NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential | 1-gen-2023 | Portale, Federica; Di Mitri, Diletta | |
| NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control | 1-gen-2018 | Bottcher, Jp; Bonavita, E; Chakravarty, P; Blees, H; Cabeza-Cabrerizo, M; Sammicheli, S; Rogers, Nc; Sahai, E; Zelenay, S; Reis, e Sousa C | |
| NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions | 1-gen-2021 | Cazzetta, Valentina; Bruni, Elena; Terzoli, Sara; Carenza, Claudia; Franzese, Sara; Piazza, Rocco; Marzano, Paolo; Donadon, Matteo; Torzilli, Guido; Cimino, Matteo; Simonelli, Matteo; Bello, Lorenzo; Villa, Anna; Tan, Likai; Ravens, Sarina; Prinz, Immo; Supino, Domenico; Colombo, Federico S; Lugli, Enrico; Marcenaro, Emanuela; Vivier, Eric; Della Bella, Silvia; Mikulak, Joanna; Mavilio, Domenico | |
| NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer | 1-gen-2019 | Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico | |
| No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study | 1-gen-2018 | Levi-Setti, P; Cirillo, F; Smeraldi, A; Morenghi, E; Mulazzani, Geg; Albani, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile